Crizonix

Uses
Crizonix contains the cancer drug Crizotinib, a kinase inhibitor indicated in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive or ROS 1 positive. Crizotinib is FDA-approved as a therapy for both ALK positive and ROS1-positive metastatic NSCLC. It is the only FDA approved drug for ROS 1 positive NSCLC.

Dosage and Administration
Each pack of Crizonix contains 28 x 250mg capsules.

Your doctor will prescribe you a specific dose. Your doctor should also advise how often to take Crizotinib, when to take Crizotinib and how long to take Crizotinib for.

Precautions
Crizonix can be used by:

• adults with ALK-positive advanced NSCLC (non-small cell lung cancer)
• adults with previously treated ALK-positive advanced NSCLC & ROS1 (+) NSCLC